{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:16Z","timestamp":1791071656300,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T00:00:00Z","timestamp":1369180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063818","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T18:43:36Z","timestamp":1369248216000},"page":"e63818","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":209,"title":["A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct00703469","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"David","family":"Gardiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lalezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DiMicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheem","family":"Ghalib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven O\u2019","family":"Marro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Kansra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McPhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Wind-Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Grasela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-979468","article-title":"Chronic infections with hepatotropic viruses: Mechanisms of impairment of cellular immune responses","volume":"27","author":"B Rehermann","year":"2007","journal-title":"Seminars in Liver Disease"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-010-0066-0","article-title":"Revisiting immune exhaustion during HIV infection","volume":"8","author":"A Khaitan","year":"2011","journal-title":"Current HIV\/AIDS Reports"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"EJ Wherry","year":"2011","journal-title":"Nature Immunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1016\/S0168-8278(11)61362-7","article-title":"Pegylated interferon-lambda (pegIFN-\u03bb) shows superior viral response with improved safety and tolerability versus pegIFN-\u03b1-2a in HCV patients (G1\/2\/3\/4): EMERGE phase IIb through week 12 [abstract]","volume":"54","author":"S Zeuzem","year":"2011","journal-title":"Journal of Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.20839","article-title":"Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection","volume":"42","author":"Y Horsmans","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMoa0903175","article-title":"Interleukin-2 therapy in patients with HIV infection","volume":"361","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAD.0b013e32831cc114","article-title":"Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: A randomized controlled trial","volume":"23","author":"BO Porter","year":"2009","journal-title":"AIDS (London, England)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/imt.10.91","article-title":"Immunotherapeutic restoration in HIV-infected individuals","volume":"3","author":"JM Kim","year":"2011","journal-title":"Immunotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence","volume":"119","author":"B Rehermann","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/655653","article-title":"Viral evolution and escape during acute HIV-1 infection","volume":"202","author":"CL Boutwell","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B virus surface antigen impairs myeloid dendritic cell function: A possible immune escape mechanism of hepatitis B virus","volume":"126","author":"ML Op den Brouw","year":"2009","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12026-009-8152-3","article-title":"Hepatitis C virus evasion of adaptive immune responses: A model for viral persistence","volume":"47","author":"KP Burke","year":"2010","journal-title":"Immunologic Research"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"DL Barber","year":"2006","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"451694","DOI":"10.1155\/2011\/451694","article-title":"The PD-1\/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion","volume":"2011","author":"KA Hofmeyer","year":"2011","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"LM Francisco","year":"2010","journal-title":"Immunological Reviews"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"AH Sharpe","year":"2007","journal-title":"Nature Immunology"},{"key":"ref17","first-page":"409","article-title":"Blockade of the B7-H1\/PD-1 pathway for cancer immunotherapy","volume":"84","author":"DB Flies","year":"2011","journal-title":"The Yale Journal of Biology and Medicine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"LM Francisco","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/intimm\/dxp072","article-title":"PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(hi) regulatory T cells","volume":"21","author":"W Wang","year":"2009","journal-title":"International Immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1078-0432.CCR-07-4079","article-title":"Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies","volume":"14","author":"R Berger","year":"2008","journal-title":"Clinical Cancer Research : An Official Journal of the American Association for Cancer Research"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"JR Brahmer","year":"2010","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Y Latchman","year":"2001","journal-title":"Nature Immunology"},{"key":"ref23","first-page":"1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Journal of Immunology (Baltimore, Md","volume":"170","author":"JA Brown","year":"2003","journal-title":": 1950)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0902-1039c","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"H Dong","year":"2002","journal-title":"Nature Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"L Trautmann","year":"2006","journal-title":"Nature Medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molimm.2007.07.038","article-title":"PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients","volume":"45","author":"G Peng","year":"2008","journal-title":"Molecular Immunology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00409-07","article-title":"Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction","volume":"81","author":"L Golden-Mason","year":"2007","journal-title":"Journal of Virology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-8-279","article-title":"Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ treg cells in chronic HCV infected-patients","volume":"8","author":"T Shen","year":"2011","journal-title":"Virology Journal"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"CL Day","year":"2006","journal-title":"Nature"},{"key":"ref30","first-page":"2714","article-title":"PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. Journal of Immunology (Baltimore, Md","volume":"178","author":"H Maier","year":"2007","journal-title":": 1950)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"C Boni","year":"2007","journal-title":"Journal of Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"A Penna","year":"2007","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"N Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+CD25+Foxp3+ tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"D Franceschini","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"ref35","first-page":"980","article-title":"PD-1 blockade in rhesus macaques: Impact on chronic infection and prophylactic vaccination. Journal of Immunology (Baltimore, Md","volume":"182","author":"AC Finnefrock","year":"2009","journal-title":": 1950)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"V Velu","year":"2009","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e19664","DOI":"10.1371\/journal.pone.0019664","article-title":"Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection","volume":"6","author":"Y Zhang","year":"2011","journal-title":"PloS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"N Nakamoto","year":"2009","journal-title":"PLoS Pathogens"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"SL Topalian","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"K Tamura","year":"2011","journal-title":"Molecular Biology and Evolution"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus","volume":"139","author":"AJ Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI200421307","article-title":"Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes","volume":"114","author":"P Achenbach","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"100","author":"KM Chang","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"SD Blackburn","year":"2009","journal-title":"Nature Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.coi.2009.01.010","article-title":"The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses","volume":"21","author":"A Crawford","year":"2009","journal-title":"Current Opinion in Immunology"},{"key":"ref48","first-page":"4217","article-title":"CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. Journal of Immunology (Baltimore, Md","volume":"188","author":"KL Good-Jacobson","year":"2012","journal-title":": 1950)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"T Okazaki","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2169\/internalmedicine.45.1530","article-title":"Immunopathogenesis of hepatitis C virus infection: Multifaceted strategies subverting innate and adaptive immunity","volume":"45","author":"T Kanto","year":"2006","journal-title":"Internal Medicine (Tokyo, Japan)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:31:41Z","timestamp":1540290701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063818"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,22]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063818","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016215.793479829","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,22]]}}}